Stephen From, President and CEO at EYEGATE PHARMACEUTICALS INC (EYEG), bought 12,500 shares at $1.03 ($13K) on 2017-08-10, disclosed to the SEC on 2017-08-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |